Category Archives: Defective Devices

Medtronic Makes 40 Job Cuts in Minnesota

Forty Medtronic employees will be losing their jobs, the company has disclosed. According to Minnepolis/St. Paul Business Journal, Medtronic has not given many details about the job cuts. Some jobs being eliminated are in Fridley, where the headquarters for its …

Read More

Stryker and Alliant Pay More than $1 Million to Resolve Whistleblower Lawsuit

The U.S. Attorney’s Office for the Central District of California has announced that Stryker Corporation and Alliant Enterprises have paid the U.S. government a total of $1.05 million to resolve a whistleblower lawsuit. The whistleblower case alleges that the companies …

Read More

$193 Million Lidoderm Settlement Announced, Whistleblowers to Be Awarded

Three whistleblowers, among them a New York pharmaceutical sales representative, provided information to federal prosecutors, which has led to a $193 million settlement over the Lidoderm Patch being marketing for unapproved uses. A doctor and a sales representative in Pennsylvania …

Read More

Huge Awards Expected for Whistleblowers in 2014, SEC says

Large awards are awaiting whistleblowers this year, say officials from the Securities and Exchange Commission. One large award has already been given, and officials promise that more large rewards are on the way. Experts who closely follow the whistleblower issues …

Read More

Medtronic’s Spine Business Soft Compared to Other Units

Device maker, Medtronic Inc., just announced company-wide increased net income; however, its spine division is seeing some sagging business Medtronic, which manufactures implantable heart devices, insulin pumps, and spine surgery products posted overall net income of $902 million for second-quarter, …

Read More

J&J Agrees to $2.2 Billion in Risperdal Whistleblower Case

In what is being described as one of the largest whistleblower payouts in the history of the United States, Johnson & Johnson agreed to pay $2.2 billion over the way in which the antipsychotic medication, Risperdal, was marketed, among other issues.

Read More